Colorectal Cancer - Pipeline Review, H2 2015

Date: December 31, 2015
Pages: 1511
Price:
US$ 2,500.00 US$ 2,125.00
Offer valid until December 31, 2016!
License [?]:
Publisher: Global Markets Direct
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: C17E15E283FEN
Leaflet:

Download PDF Leaflet

Colorectal Cancer - Pipeline Review, H2 2015

SUMMARY

Global Markets Direct’s, ‘Colorectal Cancer - Pipeline Review, H2 2015’, provides an overview of the Colorectal Cancer’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Colorectal Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Colorectal Cancer and special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

SCOPE
  • The report provides a snapshot of the global therapeutic landscape of Colorectal Cancer
  • The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
  • The report reviews key players involved in the therapeutics development for Colorectal Cancer and enlists all their major and minor projects
  • The report summarizes all the dormant and discontinued pipeline projects
  • A review of the Colorectal Cancer products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
  • Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • A detailed assessment of monotherapy and combination therapy pipeline projects
  • Coverage of the Colorectal Cancer pipeline on the basis of target, MoA, route of administration and molecule type
  • Latest news and deals relating related to pipeline products
REASONS TO BUY
  • Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop strategic initiatives by understanding the focus areas of leading companies
  • Identify and understand important and diverse types of therapeutics under development for Colorectal Cancer
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Devise corrective measures for pipeline projects by understanding Colorectal Cancer pipeline depth and focus of Indication therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
Introduction
Colorectal Cancer Overview
Therapeutics Development
Colorectal Cancer - Therapeutics under Development by Companies
Colorectal Cancer - Therapeutics under Investigation by Universities/Institutes
Colorectal Cancer - Pipeline Products Glance
Colorectal Cancer - Products under Development by Companies
Colorectal Cancer - Products under Investigation by Universities/Institutes
Colorectal Cancer - Companies Involved in Therapeutics Development
Colorectal Cancer - Therapeutics Assessment
Drug Profiles
Colorectal Cancer - Recent Pipeline Updates 1021
Colorectal Cancer - Dormant Projects 1428
Colorectal Cancer - Discontinued Products 1452
Colorectal Cancer - Product Development Milestones 1459
Appendix 1467

LIST OF TABLES

Number of Products under Development for Colorectal Cancer, H2 2015
Number of Products under Development for Colorectal Cancer - Comparative Analysis, H2 2015
Number of Products under Development by Companies, H2 2015
Number of Products under Development by Companies, H2 2015 (Contd..1)
Number of Products under Development by Companies, H2 2015 (Contd..2)
Number of Products under Development by Companies, H2 2015 (Contd..3)
Number of Products under Development by Companies, H2 2015 (Contd..4)
Number of Products under Development by Companies, H2 2015 (Contd..5)
Number of Products under Development by Companies, H2 2015 (Contd..6)
Number of Products under Development by Companies, H2 2015 (Contd..7)
Number of Products under Development by Companies, H2 2015 (Contd..8)
Number of Products under Development by Companies, H2 2015 (Contd..9)
Number of Products under Development by Companies, H2 2015 (Contd..10)
Number of Products under Development by Companies, H2 2015 (Contd..11)
Number of Products under Development by Companies, H2 2015 (Contd..12)
Number of Products under Development by Companies, H2 2015 (Contd..13)
Number of Products under Development by Companies, H2 2015 (Contd..14)
Number of Products under Development by Companies, H2 2015 (Contd..15)
Number of Products under Development by Companies, H2 2015 (Contd..16)
Number of Products under Development by Companies, H2 2015 (Contd..17)
Number of Products under Investigation by Universities/Institutes, H2 2015
Number of Products under Investigation by Universities/Institutes, H2 2015 (Contd..1)
Number of Products under Investigation by Universities/Institutes, H2 2015 (Contd..2)
Comparative Analysis by Late Stage Development, H2 2015
Comparative Analysis by Clinical Stage Development, H2 2015
Comparative Analysis by Early Stage Development, H2 2015
Comparative Analysis by Unknown Stage Development, H2 2015
Products under Development by Companies, H2 2015
Products under Development by Companies, H2 2015 (Contd..1)
Products under Development by Companies, H2 2015 (Contd..2)
Products under Development by Companies, H2 2015 (Contd..3)
Products under Development by Companies, H2 2015 (Contd..4)
Products under Development by Companies, H2 2015 (Contd..5)
Products under Development by Companies, H2 2015 (Contd..6)
Products under Development by Companies, H2 2015 (Contd..7)
Products under Development by Companies, H2 2015 (Contd..8)
Products under Development by Companies, H2 2015 (Contd..9)
Products under Development by Companies, H2 2015 (Contd..10)
Products under Development by Companies, H2 2015 (Contd..11)
Products under Development by Companies, H2 2015 (Contd..12)
Products under Development by Companies, H2 2015 (Contd..13)
Products under Development by Companies, H2 2015 (Contd..14)
Products under Development by Companies, H2 2015 (Contd..15)
Products under Development by Companies, H2 2015 (Contd..16)
Products under Development by Companies, H2 2015 (Contd..17)
Products under Development by Companies, H2 2015 (Contd..18)
Products under Development by Companies, H2 2015 (Contd..19)
Products under Development by Companies, H2 2015 (Contd..20)
Products under Development by Companies, H2 2015 (Contd..21)
Products under Development by Companies, H2 2015 (Contd..22)
Products under Development by Companies, H2 2015 (Contd..23)
Products under Investigation by Universities/Institutes, H2 2015
Products under Investigation by Universities/Institutes, H2 2015 (Contd..1)
Products under Investigation by Universities/Institutes, H2 2015 (Contd..2)
Colorectal Cancer - Pipeline by 2cureX ApS, H2 2015
Colorectal Cancer - Pipeline by 3-V Biosciences, Inc., H2 2015
Colorectal Cancer - Pipeline by 4SC AG, H2 2015
Colorectal Cancer - Pipeline by AB Science SA, H2 2015
Colorectal Cancer - Pipeline by AbbVie Inc., H2 2015
Colorectal Cancer - Pipeline by AbGenomics International, Inc., H2 2015
Colorectal Cancer - Pipeline by Actinium Pharmaceuticals, Inc., H2 2015
Colorectal Cancer - Pipeline by Adamed Sp. z o.o., H2 2015
Colorectal Cancer - Pipeline by Advaxis, Inc., H2 2015
Colorectal Cancer - Pipeline by Advenchen Laboratories, LLC, H2 2015
Colorectal Cancer - Pipeline by Alchemia Limited, H2 2015
Colorectal Cancer - Pipeline by Allinky Biopharma, H2 2015
Colorectal Cancer - Pipeline by Amgen Inc., H2 2015
Colorectal Cancer - Pipeline by Antibe Therapeutics, Inc., H2 2015
Colorectal Cancer - Pipeline by Apexigen, Inc., H2 2015
Colorectal Cancer - Pipeline by Aphios Corporation, H2 2015
Colorectal Cancer - Pipeline by Aposense Ltd., H2 2015
Colorectal Cancer - Pipeline by Arisaph Pharmaceuticals, Inc., H2 2015
Colorectal Cancer - Pipeline by ArQule, Inc., H2 2015
Colorectal Cancer - Pipeline by Array BioPharma Inc., H2 2015
Colorectal Cancer - Pipeline by Astellas Pharma Inc., H2 2015
Colorectal Cancer - Pipeline by Astex Pharmaceuticals, Inc., H2 2015
Colorectal Cancer - Pipeline by AstraZeneca Plc, H2 2015
Colorectal Cancer - Pipeline by ATLAB Pharma SAS, H2 2015
Colorectal Cancer - Pipeline by AVEO Pharmaceuticals, Inc., H2 2015
Colorectal Cancer - Pipeline by Basilea Pharmaceutica AG, H2 2015
Colorectal Cancer - Pipeline by Bavarian Nordic A/S, H2 2015
Colorectal Cancer - Pipeline by Baxalta Incorporated, H2 2015
Colorectal Cancer - Pipeline by Bayer AG, H2 2015
Colorectal Cancer - Pipeline by BeiGene(Beijing) Co.,Ltd, H2 2015
Colorectal Cancer - Pipeline by BioAtla, LLC, H2 2015
Colorectal Cancer - Pipeline by Biocon Limited, H2 2015
Colorectal Cancer - Pipeline by Bionomics Limited, H2 2015
Colorectal Cancer - Pipeline by Bionovis SA, H2 2015
Colorectal Cancer - Pipeline by Biotecnol, Inc., H2 2015
Colorectal Cancer - Pipeline by Biothera, Inc., H2 2015
Colorectal Cancer - Pipeline by Boehringer Ingelheim GmbH, H2 2015
Colorectal Cancer - Pipeline by Boston Biomedical, Inc., H2 2015
Colorectal Cancer - Pipeline by Bristol-Myers Squibb Company, H2 2015
Colorectal Cancer - Pipeline by Burzynski Research Institute, Inc., H2 2015
Colorectal Cancer - Pipeline by cCAM Biotherapeutics Ltd., H2 2015
Colorectal Cancer - Pipeline by CCRP Therapeutics GmbH, H2 2015
Colorectal Cancer - Pipeline by Celator Pharmaceuticals, Inc., H2 2015
Colorectal Cancer - Pipeline by Celgene Corporation, H2 2015
Colorectal Cancer - Pipeline by Cellceutix Corporation, H2 2015
Colorectal Cancer - Pipeline by Celldex Therapeutics, Inc., H2 2015
Colorectal Cancer - Pipeline by Cellectar Biosciences, Inc., H2 2015
Colorectal Cancer - Pipeline by Celltrion, Inc., H2 2015
Colorectal Cancer - Pipeline by Celon Pharma Sp. z o.o., H2 2015
Colorectal Cancer - Pipeline by Chipscreen Biosciences Ltd, H2 2015
Colorectal Cancer - Pipeline by Cleave Biosciences, H2 2015
Colorectal Cancer - Pipeline by Coare Biotechnology, Inc., H2 2015
Colorectal Cancer - Pipeline by Cornerstone Pharmaceuticals, Inc., H2 2015
Colorectal Cancer - Pipeline by Critical Outcome Technologies Inc., H2 2015
Colorectal Cancer - Pipeline by CritiTech, Inc., H2 2015
Colorectal Cancer - Pipeline by CrystalGenomics, Inc., H2 2015
Colorectal Cancer - Pipeline by CTI BioPharma Corp., H2 2015
Colorectal Cancer - Pipeline by Cytune Pharma SAS, H2 2015
Colorectal Cancer - Pipeline by Daiichi Sankyo Company, Limited, H2 2015
Colorectal Cancer - Pipeline by DanDrit Biotech A/S, H2 2015
Colorectal Cancer - Pipeline by Deciphera Pharmaceuticals, LLC, H2 2015
Colorectal Cancer - Pipeline by Dicerna Pharmaceuticals, Inc., H2 2015
Colorectal Cancer - Pipeline by Digna Biotech, S.L., H2 2015
Colorectal Cancer - Pipeline by Double Bond Pharmaceutical International AB, H2 2015
Colorectal Cancer - Pipeline by Dr. Reddy's Laboratories Limited, H2 2015
Colorectal Cancer - Pipeline by EirGenix Inc., H2 2015
Colorectal Cancer - Pipeline by Eisai Co., Ltd., H2 2015
Colorectal Cancer - Pipeline by Eli Lilly and Company, H2 2015
Colorectal Cancer - Pipeline by Endor Nanotechnologies SL, H2 2015
Colorectal Cancer - Pipeline by enGene, Inc, H2 2015
Colorectal Cancer - Pipeline by EnGeneIC Ltd, H2 2015
Colorectal Cancer - Pipeline by Ensol Biosciences Inc., H2 2015
Colorectal Cancer - Pipeline by EntreChem, S.L., H2 2015
Colorectal Cancer - Pipeline by Enzo Biochem, Inc., H2 2015
Colorectal Cancer - Pipeline by Epirus Biopharmaceuticals, Inc., H2 2015
Colorectal Cancer - Pipeline by Erytech Pharma SA, H2 2015
Colorectal Cancer - Pipeline by Etubics Corporation, H2 2015
Colorectal Cancer - Pipeline by Exelixis, Inc., H2 2015
Colorectal Cancer - Pipeline by F. Hoffmann-La Roche Ltd., H2 2015
Colorectal Cancer - Pipeline by Five Prime Therapeutics, Inc., H2 2015
Colorectal Cancer - Pipeline by Fusion Antibodies Limited, H2 2015
Colorectal Cancer - Pipeline by Genentech, Inc., H2 2015
Colorectal Cancer - Pipeline by Genor BioPharma Co., Ltd., H2 2015
Colorectal Cancer - Pipeline by Genoscience Pharma, H2 2015
Colorectal Cancer - Pipeline by Genzyme Corporation, H2 2015
Colorectal Cancer - Pipeline by GlaxoSmithKline Plc, H2 2015
Colorectal Cancer - Pipeline by Glycotope GmbH, H2 2015
Colorectal Cancer - Pipeline by Golden Biotechnology Corp., H2 2015
Colorectal Cancer - Pipeline by Green Cross Corporation, H2 2015
Colorectal Cancer - Pipeline by Hadasit Medical Research Services & Development Ltd, H2 2015
Colorectal Cancer - Pipeline by Hanmi Pharmaceuticals, Co. Ltd., H2 2015
Colorectal Cancer - Pipeline by Hemispherx Biopharma, Inc., H2 2015
Colorectal Cancer - Pipeline by Hetero Drugs Limited, H2 2015
Colorectal Cancer - Pipeline by Hospira, Inc., H2 2015
Colorectal Cancer - Pipeline by Hutchison MediPharma Limited, H2 2015
Colorectal Cancer - Pipeline by iDD biotech SAS, H2 2015
Colorectal Cancer - Pipeline by Ignyta, Inc., H2 2015
Colorectal Cancer - Pipeline by immatics biotechnologies GmbH, H2 2015
Colorectal Cancer - Pipeline by Immodulon Therapeutics Ltd., H2 2015
Colorectal Cancer - Pipeline by ImmuneXcite, Inc., H2 2015
Colorectal Cancer - Pipeline by ImmunNovative Developments SL, H2 2015
Colorectal Cancer - Pipeline by Immunomedics, Inc., H2 2015
Colorectal Cancer - Pipeline by Immunovative Therapies, Ltd., H2 2015
Colorectal Cancer - Pipeline by Inbiopro Solutions Pvt. Ltd., H2 2015
Colorectal Cancer - Pipeline by Incanthera Ltd., H2 2015
Colorectal Cancer - Pipeline by Incyte Corporation, H2 2015
Colorectal Cancer - Pipeline by Innovent Biologics, Inc., H2 2015
Colorectal Cancer - Pipeline by Interprotein Corporation, H2 2015
Colorectal Cancer - Pipeline by Ionis Pharmaceuticals, Inc., H2 2015
Colorectal Cancer - Pipeline by Isofol Medical AB, H2 2015
Colorectal Cancer - Pipeline by ISU ABXIS Co.,Ltd., H2 2015
Colorectal Cancer - Pipeline by Jiangsu Hengrui Medicine Co., Ltd., H2 2015
Colorectal Cancer - Pipeline by Kadmon Corporation, LLC, H2 2015
Colorectal Cancer - Pipeline by KAEL-GemVax Co., Ltd., H2 2015
Colorectal Cancer - Pipeline by KaloBios Pharmaceuticals, Inc., H2 2015
Colorectal Cancer - Pipeline by Kancera AB, H2 2015
Colorectal Cancer - Pipeline by Karyopharm Therapeutics, Inc., H2 2015
Colorectal Cancer - Pipeline by Kura Oncology, Inc., H2 2015
Colorectal Cancer - Pipeline by Kyowa Hakko Kirin Co., Ltd., H2 2015
Colorectal Cancer - Pipeline by Laboratorio Elea S.A.C.I.F. and A, H2 2015
Colorectal Cancer - Pipeline by Lee's Pharmaceutical Holdings Limited, H2 2015
Colorectal Cancer - Pipeline by LivTech, Inc., H2 2015
Colorectal Cancer - Pipeline by Loxo Oncology, Inc., H2 2015
Colorectal Cancer - Pipeline by Mabion SA, H2 2015
Colorectal Cancer - Pipeline by Mabtech Limited, H2 2015
Colorectal Cancer - Pipeline by mAbxience S.A., H2 2015
Colorectal Cancer - Pipeline by MacroGenics, Inc., H2 2015
Colorectal Cancer - Pipeline by MedImmune, LLC, H2 2015
Colorectal Cancer - Pipeline by Medivation, Inc., H2 2015
Colorectal Cancer - Pipeline by Merck & Co., Inc., H2 2015
Colorectal Cancer - Pipeline by Merck KGaA, H2 2015
Colorectal Cancer - Pipeline by Merrimack Pharmaceuticals, Inc., H2 2015
Colorectal Cancer - Pipeline by Merus B.V., H2 2015
Colorectal Cancer - Pipeline by Millennium Pharmaceuticals, Inc., H2 2015
Colorectal Cancer - Pipeline by Mirna Therapeutics, Inc., H2 2015
Colorectal Cancer - Pipeline by MolMed S.p.A., H2 2015
Colorectal Cancer - Pipeline by Mologen AG, H2 2015
Colorectal Cancer - Pipeline by Momenta Pharmaceuticals, Inc., H2 2015
Colorectal Cancer - Pipeline by Morphotek, Inc., H2 2015
Colorectal Cancer - Pipeline by Multimmune GmbH, H2 2015
Colorectal Cancer - Pipeline by Mycenax Biotech Inc., H2 2015
Colorectal Cancer - Pipeline by Natco Pharma Limited, H2 2015
Colorectal Cancer - Pipeline by NatureWise Biotech & Medicals Corporation, H2 2015
Colorectal Cancer - Pipeline by Nektar Therapeutics, H2 2015
Colorectal Cancer - Pipeline by Neovacs SA, H2 2015
Colorectal Cancer - Pipeline by Nerviano Medical Sciences S.r.l., H2 2015
Colorectal Cancer - Pipeline by Nippon Kayaku Co., Ltd., H2 2015
Colorectal Cancer - Pipeline by NormOxys, Inc., H2 2015
Colorectal Cancer - Pipeline by Northwest Biotherapeutics, Inc., H2 2015
Colorectal Cancer - Pipeline by Novartis AG, H2 2015
Colorectal Cancer - Pipeline by NuCana BioMed Limited, H2 2015
Colorectal Cancer - Pipeline by OBI Pharma, Inc., H2 2015
Colorectal Cancer - Pipeline by Oncobiologics, Inc., H2 2015
Colorectal Cancer - Pipeline by Oncology Research International Limited, H2 2015
Colorectal Cancer - Pipeline by Oncolytics Biotech Inc., H2 2015
Colorectal Cancer - Pipeline by OncoMed Pharmaceuticals, Inc., H2 2015
Colorectal Cancer - Pipeline by Onconova Therapeutics, Inc., H2 2015
Colorectal Cancer - Pipeline by Oncothyreon Inc., H2 2015
Colorectal Cancer - Pipeline by Oryx GmbH & Co. KG, H2 2015
Colorectal Cancer - Pipeline by Otsuka Holdings Co., Ltd., H2 2015
Colorectal Cancer - Pipeline by Oxford BioMedica Plc, H2 2015
Colorectal Cancer - Pipeline by Panacea Biotec Limited, H2 2015
Colorectal Cancer - Pipeline by Pfizer Inc., H2 2015
Colorectal Cancer - Pipeline by Pharma Mar, S.A., H2 2015

LIST OF FIGURES

Number of Products under Development for Colorectal Cancer, H2 2015
Number of Products under Development for Colorectal Cancer - Comparative Analysis, H2 2015
Number of Products under Development by Companies, H2 2015
Number of Products under Investigation by Universities/Institutes, H2 2015
Comparative Analysis by Late Stage Development, H2 2015
Comparative Analysis by Clinical Stage Development, H2 2015
Comparative Analysis by Early Stage Products, H2 2015
Assessment by Monotherapy Products, H2 2015
Assessment by Combination Products, H2 2015
Number of Products by Top 10 Targets, H2 2015
Number of Products by Stage and Top 10 Targets, H2 2015
Number of Products by Top 10 Mechanism of Actions, H2 2015
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2015
Number of Products by Top 10 Routes of Administration, H2 2015
Number of Products by Stage and Top 10 Routes of Administration, H2 2015
Number of Products by Top 10 Molecule Types, H2 2015
Number of Products by Stage and Top 10 Molecule Types, H2 2015

COMPANIES MENTIONED

2cureX ApS
3-V Biosciences, Inc.
4SC AG
AB Science SA
AbbVie Inc.
AbGenomics International, Inc.
Actinium Pharmaceuticals, Inc.
Adamed Sp. z o.o.
Advaxis, Inc.
Advenchen Laboratories, LLC
Alchemia Limited
Allinky Biopharma
Amgen Inc.
Antibe Therapeutics, Inc.
Apexigen, Inc.
Aphios Corporation
Aposense Ltd.
Arisaph Pharmaceuticals, Inc.
ArQule, Inc.
Array BioPharma Inc.
Astellas Pharma Inc.
Astex Pharmaceuticals, Inc.
AstraZeneca Plc
ATLAB Pharma SAS
AVEO Pharmaceuticals, Inc.
Basilea Pharmaceutica AG
Bavarian Nordic A/S
Baxalta Incorporated
Bayer AG
BeiGene(Beijing) Co.,Ltd
BioAtla, LLC
Biocon Limited
Bionomics Limited
Bionovis SA
Biotecnol, Inc.
Biothera, Inc.
Boehringer Ingelheim GmbH
Boston Biomedical, Inc.
Bristol-Myers Squibb Company
Burzynski Research Institute, Inc.
cCAM Biotherapeutics Ltd.
CCRP Therapeutics GmbH
Celator Pharmaceuticals, Inc.
Celgene Corporation
Cellceutix Corporation
Celldex Therapeutics, Inc.
Cellectar Biosciences, Inc.
Celltrion, Inc.
Celon Pharma Sp. z o.o.
Chipscreen Biosciences Ltd
Cleave Biosciences
Coare Biotechnology, Inc.
Cornerstone Pharmaceuticals, Inc.
Critical Outcome Technologies Inc.
CritiTech, Inc.
CrystalGenomics, Inc.
CTI BioPharma Corp.
Cytune Pharma SAS
Daiichi Sankyo Company, Limited
DanDrit Biotech A/S
Deciphera Pharmaceuticals, LLC
Dicerna Pharmaceuticals, Inc.
Digna Biotech, S.L.
Double Bond Pharmaceutical International AB
Dr. Reddy's Laboratories Limited
EirGenix Inc.
Eisai Co., Ltd.
Eli Lilly and Company
Endor Nanotechnologies SL
enGene, Inc
EnGeneIC Ltd
Ensol Biosciences Inc.
EntreChem, S.L.
Enzo Biochem, Inc.
Epirus Biopharmaceuticals, Inc.
Erytech Pharma SA
Etubics Corporation
Exelixis, Inc.
F. Hoffmann-La Roche Ltd.
Five Prime Therapeutics, Inc.
Fusion Antibodies Limited
Genentech, Inc.
Genor BioPharma Co., Ltd.
Genoscience Pharma
Genzyme Corporation
GlaxoSmithKline Plc
Glycotope GmbH
Golden Biotechnology Corp.
Green Cross Corporation
Hadasit Medical Research Services & Development Ltd
Hanmi Pharmaceuticals, Co. Ltd.
Hemispherx Biopharma, Inc.
Hetero Drugs Limited
Hospira, Inc.
Hutchison MediPharma Limited
iDD biotech SAS
Ignyta, Inc.
immatics biotechnologies GmbH
Immodulon Therapeutics Ltd.
ImmuneXcite, Inc.
ImmunNovative Developments SL
Immunomedics, Inc.
Immunovative Therapies, Ltd.
Inbiopro Solutions Pvt. Ltd.
Incanthera Ltd.
Incyte Corporation
Innovent Biologics, Inc.
Interprotein Corporation
Ionis Pharmaceuticals, Inc.
Isofol Medical AB
ISU ABXIS Co.,Ltd.
Jiangsu Hengrui Medicine Co., Ltd.
Kadmon Corporation, LLC
KAEL-GemVax Co., Ltd.
KaloBios Pharmaceuticals, Inc.
Kancera AB
Karyopharm Therapeutics, Inc.
Kura Oncology, Inc.
Kyowa Hakko Kirin Co., Ltd.
Laboratorio Elea S.A.C.I.F. and A
Lee's Pharmaceutical Holdings Limited
LivTech, Inc.
Loxo Oncology, Inc.
Mabion SA
Mabtech Limited
mAbxience S.A.
MacroGenics, Inc.
MedImmune, LLC
Medivation, Inc.
Merck & Co., Inc.
Merck KGaA
Merrimack Pharmaceuticals, Inc.
Merus B.V.
Millennium Pharmaceuticals, Inc.
Mirna Therapeutics, Inc.
MolMed S.p.A.
Mologen AG
Momenta Pharmaceuticals, Inc.
Morphotek, Inc.
Multimmune GmbH
Mycenax Biotech Inc.
Natco Pharma Limited
NatureWise Biotech & Medicals Corporation
Nektar Therapeutics
Neovacs SA
Nerviano Medical Sciences S.r.l.
Nippon Kayaku Co., Ltd.
NormOxys, Inc.
Northwest Biotherapeutics, Inc.
Novartis AG
NuCana BioMed Limited
OBI Pharma, Inc.
Oncobiologics, Inc.
Oncology Research International Limited
Oncolytics Biotech Inc.
OncoMed Pharmaceuticals, Inc.
Onconova Therapeutics, Inc.
Oncothyreon Inc.
Oryx GmbH & Co. KG
Otsuka Holdings Co., Ltd.
Oxford BioMedica Plc
Panacea Biotec Limited
Pfizer Inc.
Pharma Mar, S.A.
Pharmacyclics, Inc.
Pivotal BioSciences, Inc.
Plexxikon Inc.
PLx Pharma Inc.
Precision Biologics, Inc.
PsiOxus Therapeutics Limited
Puma Biotechnology, Inc.
Quimatryx, S.L.
Redx Pharma Plc
Regeneron Pharmaceuticals, Inc.
Rexahn Pharmaceuticals, Inc.
Sanofi
Selvita SA
Serina Therapeutics, Inc.
Shanghai Henlius Biotech Co., Ltd.
Sigmoid Pharma Limited
Sillajen Biotherapeutics
Sirnaomics, Inc.
Solvotrin Therapeutics Limited
Sorrento Therapeutics, Inc.
Sumitomo Dainippon Pharma Co., Ltd.
Sunesis Pharmaceuticals, Inc.
SuviCa Inc.
Symphogen A/S
Syndax Pharmaceuticals, Inc.
Tara Immuno-Oncology Therapeutics LLC
Targovax AS
TetraLogic Pharmaceuticals
Teva Pharmaceutical Industries Limited
TG Therapeutics, Inc.
Theravectys SA
TRACON Pharmaceuticals, Inc.
Transgene SA
Vaccinex, Inc.
VasGene Therapeutics, Inc.
Verlyx Pharma Inc.
Vertex Pharmaceuticals Incorporated
Viralytics Ltd.
Wilex AG
WntResearch AB
XBiotech USA, Inc.
Zymeworks Inc.
Zyngenia, Inc.
Skip to top


Ask Your Question

Colorectal Cancer - Pipeline Review, H2 2015
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: